Results 11 to 20 of about 10,730,025 (313)

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

Revue neurologique (Paris), 2020
In France, the epidemic phase of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in February 2020 and resulted in the implementation of emergency measures and a degradation in the organization of neuromuscular ...
G. Solé, E. Salort-Campana, Y. Péréon, T. Stojkovic, K. Wahbi, P. Cintas, D. Adams, P. Laforêt, V. Tiffreau, Isabelle Desguerre, L. Pisella, A. Molon, S. Attarian   +12 more
semanticscholar   +1 more source

Cross-sectorial collaboration on policy-driven rehabilitation care models for persons with neuromuscular diseases: reflections and behavior of community-based health professionals

BMC Health Services Research, 2022
Background Persons with neuromuscular diseases (NMDs) often experience complex rehabilitation needs due to the disease’s impact on their functioning and progression of their diseases.
Charlotte Handberg, Ulla Werlauff
doaj   +1 more source

Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results

International Journal of Molecular Sciences, 2020
Skeletal muscle and the nervous system depend on efficient protein quality control, and they express chaperones and cochaperones at high levels to maintain protein homeostasis. Mutations in many of these proteins cause neuromuscular diseases, myopathies,
J. Sarparanta, P. Jonson, S. Kawan, B. Udd   +3 more
semanticscholar   +1 more source

A highly prevalent SINE mutation in the myostatin (MSTN) gene promoter is associated with low circulating myostatin concentration in Thoroughbred racehorses

Scientific Reports, 2021
Horse racing is a popular and financially important industry worldwide and researchers and horse owners are interested in genetic and training influences that maximise athletic performance.
Victoria O’Hara, Amélie Cowan, Dominique Riddell, Claire Massey, John Martin, Richard J. Piercy   +5 more
doaj   +1 more source

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases

Antioxidants, 2020
Neuromuscular diseases (NMDs) are a heterogeneous group of acquired or inherited rare disorders caused by injury or dysfunction of the anterior horn cells of the spinal cord (lower motor neurons), peripheral nerves, neuromuscular junctions, or skeletal ...
Judith Cantó-Santos, J. M. Grau-Junyent, G. Garrabou   +2 more
semanticscholar   +1 more source

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

Biomedicines, 2022
The complement system plays a key role in myasthenia gravis (MG). Anti-complement drugs are emerging as effective therapies to treat anti-acetylcholine receptor (AChR) antibody-positive MG patients, though their usage is still limited by the high costs ...
Nicola Iacomino, Fiammetta Vanoli, Rita Frangiamore, Marta Ballardini, Letizia Scandiffio, Federica Bortone, Francesca Andreetta, Fulvio Baggi, Pia Bernasconi, Carlo Antozzi, Paola Cavalcante, Renato Mantegazza   +11 more
doaj   +1 more source

Dysphagia and Dysarthria in Children with Neuromuscular Diseases, a Prevalence Study

Journal of Neuromuscular Diseases, 2020
Background: Dysphagia and dysarthria are frequently described in pediatric neuromuscular diseases (pNMD). The consequences can be substantial: failure to thrive, malnutrition, aspiration pneumonia, or communication problems.
Mieke Kooi-van Es, C. Erasmus, B. D. de Swart, Nicoline B. M. Voet, P. J. van der Wees, Imelda J. M. de Groot, L. van den Engel-Hoek   +6 more
semanticscholar   +1 more source

BDNF-dependent modulation of axonal transport is selectively impaired in ALS

Acta Neuropathologica Communications, 2022
Axonal transport ensures long-range delivery of essential cargoes between proximal and distal compartments, and is needed for neuronal development, function, and survival.
Andrew P. Tosolini, James N. Sleigh, Sunaina Surana, Elena R. Rhymes, Stephen D. Cahalan, Giampietro Schiavo   +5 more
doaj   +1 more source

Neuromuscular Diseases Care in the Era of COVID-19

Frontiers in Neurology, 2020
The COVID-19 pandemic has pushed health systems to their limit and forced readjustment of standards of care for different pathologies. Management of neuromuscular diseases becomes a challenge since most of them are chronic, disabling, progressive, and/or
B. Bertrán Recasens, M. Rubio
semanticscholar   +1 more source

Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases

Neurology and Therapy, 2023
Background We have aimed to assess whether muscle thickness ultrasound (US) shows differences between patients with chronic inflammatory demyelinating polyneuropathy (CIDP), chronic axonal polyneuropathy (CAP), and other neuromuscular (NM) diseases ...
Sara A. Alnajjar, Davood Fathihelabad, Alon Abraham, Lubna Daniyal, Leif Erik Lovblom, Vera Bril   +5 more
doaj   +1 more source